









Mercados
/
Ações
/
nasdaq-akba
/

Akebia Therapeutics Inc

AKBA

2.040USD

+0.030+1.49%

Fechamento 11/07, 16:00（ET）Cotações atrasadas em 15 min

536.61MValor de mercado

PerdaP/L TTM



Akebia Therapeutics Inc

2.040

+0.030+1.49%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Akebia Therapeutics Inc Empresa

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company. The Company is focused on developing and commercializing therapeutics. The Company’s portfolio and hypoxia-inducible factor (HIF)-based pipeline includes Auryxia (ferric citrate), Vafseo (vadadustat), AKB-9090 and AKB-10108. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the United States for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Vafseo (vadadustat) is a HIF prolyl hydroxylase (HIF-PH), inhibitor, approved in 36 countries as a treatment for anemia due to chronic kidney disease (CKD). It utilizes third parties for the commercial distribution of Auryxia, including wholesale distributors and certain specialty pharmacy providers.

Informações de Akebia Therapeutics Inc



Código da empresaAKBA

Nome da EmpresaAkebia Therapeutics Inc

Data de listagemMar 20, 2014

CEOMr. John P. Butler

Número de funcionários181

Tipo de títulosOrdinary Share

Fim do ano fiscalMar 20

Endereço245 First Street

CidadeCAMBRIDGE

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal02142

Telefone16178712098

Sitehttps://akebia.com/

Código da empresaAKBA

Data de listagemMar 20, 2014

CEOMr. John P. Butler

Executivos da empresa Akebia Therapeutics Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. John P. Butler

President, Chief Executive Officer, Director

1.68M

-17.18%

Mr. Adrian Adams

Independent Chairman of the Board

170.50K

+26.48%

Mr. Michael W. Rogers

Independent Director

131.73K

+37.18%

Ms. Cynthia Smith

Independent Director

130.93K

+37.49%

Dr. Steven C. Gilman, Ph.D.

Independent Director

122.83K

+40.97%

Dr. Myles Wolf, M.D.

Independent Director

103.38K

+52.75%

Ms. Leanne M. Zumwalt

Independent Director

79.40K

+81.69%

Mr. Nicholas (Nik) Grund

Senior Vice President, Chief Commercial Officer

45.48K

-89.72%

Mr. Erik Ostrowski

Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer

-100.00%

Dr. Steven K. Burke, M.D.

Senior Vice President - Research and Development, Chief Medical Officer

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. John P. Butler

President, Chief Executive Officer, Director

1.68M

-17.18%

Mr. Adrian Adams

Independent Chairman of the Board

170.50K

+26.48%

Mr. Michael W. Rogers

Independent Director

131.73K

+37.18%

Ms. Cynthia Smith

Independent Director

130.93K

+37.49%

Dr. Steven C. Gilman, Ph.D.

Independent Director

122.83K

+40.97%

Dr. Myles Wolf, M.D.

Independent Director

103.38K

+52.75%

Detalhamento da receita

Sem dados

Sem dados

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: ter, 19 de ago

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

6.25%

The Vanguard Group, Inc.

5.84%

State Street Investment Management (US)

3.02%

Geode Capital Management, L.L.C.

2.29%

Alerce Investment Management, L.P.

2.17%

Outro

80.43%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

6.25%

The Vanguard Group, Inc.

5.84%

State Street Investment Management (US)

3.02%

Geode Capital Management, L.L.C.

2.29%

Alerce Investment Management, L.P.

2.17%

Outro

80.43%

Tipos de investidores

Investidores

Proporção

Investment Advisor

17.20%

Investment Advisor/Hedge Fund

13.14%

Hedge Fund

7.04%

Research Firm

4.02%

Individual Investor

3.57%

Private Equity

2.17%

Bank and Trust

0.20%

Pension Fund

0.16%

Venture Capital

0.06%

Outro

52.45%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

299

117.08M

44.16%

+9.43M

2025Q2

284

112.41M

42.78%

+33.09M

2025Q1

280

111.54M

42.50%

+30.68M

2024Q4

258

78.54M

36.08%

+7.41M

2024Q3

257

64.16M

30.51%

-2.18M

2024Q2

248

61.31M

29.27%

-7.52M

2024Q1

290

61.37M

29.36%

-12.30M

2023Q4

289

58.79M

31.24%

-20.79M

2023Q3

300

57.28M

30.45%

-25.18M

2023Q2

308

56.18M

30.22%

-26.52M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

16.58M

6.25%

+2.61M

+18.71%

Jun 30, 2025

The Vanguard Group, Inc.

14.61M

5.51%

+1.93M

+15.18%

Jun 30, 2025

State Street Investment Management (US)

8.00M

3.02%

+1.19M

+17.50%

Jun 30, 2025

Geode Capital Management, L.L.C.

6.07M

2.29%

+1.04M

+20.75%

Jun 30, 2025

Alerce Investment Management, L.P.

5.75M

2.17%

Dec 31, 2024

Satter Muneer A

5.75M

2.17%

+5.75M

Dec 31, 2024

Morgan Stanley & Co. LLC

4.34M

1.64%

+2.26M

+108.33%

Jun 30, 2025

Renaissance Technologies LLC

4.19M

1.58%

+188.60K

+4.71%

Jun 30, 2025

Goldman Sachs & Company, Inc.

3.53M

1.33%

+1.07M

+43.71%

Jun 30, 2025

MPM BioImpact LLC

2.89M

1.09%

+2.89M

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

Invesco Biotechnology & Genome ETF

2.36%

Invesco NASDAQ Future Gen 200 ETF

0.42%

ALPS Medical Breakthroughs ETF

0.42%

SPDR S&P Biotech ETF

0.34%

Federated Hermes MDT Small Cap Core ETF

0.2%

Direxion Daily S&P Biotech Bull 3X Shares

0.18%

iShares Micro-Cap ETF

0.13%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.11%

Vanguard US Momentum Factor ETF

0.1%

Fidelity Enhanced Small Cap ETF

0.09%

Ver Mais

Invesco Biotechnology & Genome ETF

Proporção2.36%

Invesco NASDAQ Future Gen 200 ETF

Proporção0.42%

ALPS Medical Breakthroughs ETF

Proporção0.42%

SPDR S&P Biotech ETF

Proporção0.34%

Federated Hermes MDT Small Cap Core ETF

Proporção0.2%

Direxion Daily S&P Biotech Bull 3X Shares

Proporção0.18%

iShares Micro-Cap ETF

Proporção0.13%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proporção0.11%

Vanguard US Momentum Factor ETF

Proporção0.1%

Fidelity Enhanced Small Cap ETF

Proporção0.09%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

